Carregant...
Acquired Resistance to Targeted Therapies against Oncogene-Driven Non-Small Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications
In the emerging era of targeted therapy for advanced stage non-small cell lung cancer (NSCLC), it is becoming increasingly important to anticipate potential underlying driver oncogene alterations at the time of initial diagnosis and tumor tissue acquisition, so that patients can be selected in a tim...
Guardat en:
| Publicat a: | Clin Lung Cancer |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4586161/ https://ncbi.nlm.nih.gov/pubmed/24176733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2013.10.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|